🇫🇷 France Country × Condition
bipolar disorder Clinical Trials in France
Active clinical trials for bipolar disorder with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 6 // Recruiting: 6 // Updated: Daily
Total Trials
6
Recruiting Now
6
Country
🇫🇷 France
Active Trials in France (6)
NCT06059313
Recruiting
Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders
Enrollment
120 pts
Country
🇫🇷 France
Nantes University Hospital
View Trial → NCT02878408
Recruiting
Immuno-Genetic, Inflammation, Retro-Virus, Environment
Enrollment
1,100 pts
Country
🇫🇷 France
Pr. Marion Leboyer
View Trial → NCT05802446
Recruiting
Neurofeedback for Bipolar Disorder
Enrollment
64 pts
Country
🇫🇷 France
Assistance Publique - Hôpitaux de P...
View Trial → NCT07033923
Recruiting
Neuro-computational Study of Thymic Fluctuations in Mood Disorders
Enrollment
588 pts
Country
🇫🇷 France
Centre Hospitalier St Anne
View Trial → NCT04946916
Recruiting
Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease
Enrollment
120 pts
Country
🇫🇷 France
Hôpital le Vinatier
View Trial → NCT05698589
Recruiting
COMpassion for Psychiatric Disorders And Self-Stigma
Enrollment
336 pts
Country
🇫🇷 France
University Hospital, Strasbourg, Fr...
View Trial → Frequently Asked Questions
How many bipolar disorder clinical trials are active in France?
There are currently 6 active clinical trials for bipolar disorder with sites in France, of which 6 are actively recruiting patients.
How can I join a bipolar disorder clinical trial in France?
To join a bipolar disorder clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are bipolar disorder trials in France?
Active bipolar disorder trials in France span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology